BPC-157 / TB-500

The BPC-157 / TB-500 blend pairs two of the most studied tissue-repair research peptides in a single vial. BPC-157 is a 15-amino-acid peptide modeled on a protective protein found in human stomach fluid. TB-500 is a synthetic fragment of thymosin beta-4, a protein found in nearly every cell. Vendors typically sell the pair pre-mixed at a fixed ratio, most often 5 mg of each in a 10 mg vial or 10 mg of each in a 20 mg vial, so laboratories can study the two side by side. It is sold strictly for laboratory research and is not approved for human use.

The blend exists because two separate research literatures grew up around the same repair questions. BPC-157 research began in the early 1990s at the University of Zagreb, where Predrag Sikiric and colleagues studied a protective factor from gastric juice across tendons, muscles, gut, and nerves in animal models. Thymosin beta-4, the parent protein of TB-500, was studied over the same decades for actin regulation, cell migration, and wound repair in skin, eye, and heart models. As both compounds became staples of tissue-repair research, vendors began offering them pre-mixed in one vial at a fixed ratio. The published record still covers the pair mostly separately: a single controlled rat study has tested the combination directly.

The two components reach tissue repair from different directions, which is the rationale for the pairing. BPC-157 is associated in laboratory studies with new blood vessel growth, growth-factor pathways, nitric oxide signaling, and protection of the gut lining. TB-500 is tied to actin regulation: it helps repair cells migrate to an injury site, and it is also linked to vessel growth and calmer inflammatory signaling. Researchers study the pair side by side because the two records overlap on repair questions without sharing one mechanism. That complementarity is a rationale drawn from the separate literatures, not a proven combined effect.